Roche CEO Severin Schwan Fueled By Innovation, Emerging Markets: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Roche CEO Severin Schwan says the Swiss group’s recent revamps, lack of patent expiries, and ongoing drug innovations give the world’s largest maker of cancer drugs a strong position to expand its sales globally, helped by new cutting-edge therapies and creative business approaches.